Margaret G McGlynn insider trades

Open-market stock purchases and sales by Margaret G McGlynn, Director at Novavax Inc, from SEC Form 4 filings since Dec 31, 2009.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +41%.

Recent trades

DateStockTradeValue
Jun 20, 2026NVAX Novavax IncBought (not open market)—
Jun 18, 2026NVAX Novavax IncBought (not open market)—
Jun 18, 2026NVAX Novavax IncBought (not open market)—
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$1.4M
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$140K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$234K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$134K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$238K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$387K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$388K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$385K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$436K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$446K

Companies traded

  • NVAX Novavax Inc: other filings, last Jun 20, 2026
  • FOLD Amicus Therapeutics, Inc: 1 buy, 8 sales, last Apr 27, 2026
  • VRTX Vertex Pharmaceuticals Inc / MA: 1 buy, 25 sales, last May 1, 2023
  • APD AIR Products & Chemicals Inc /de/: other filings, last Sep 30, 2020

Get free alerts when Margaret G McGlynn files a new trade →